Axon Q2 Revenue Hits $904M, Up 35%; Raises Full-Year Growth Outlook to 34%
AXON sits 67% above its 52-week low of $339.01.
Summary
Axon delivered a standout Q2 with revenue surging 35% to $904 million, marking its 10th straight quarter of 30%+ growth. Annual recurring revenue jumped 39% to $1.6 billion, and net revenue retention hit 126%, signaling strong customer expansion. The AI Era plan is scaling rapidly—revenue up nearly 700%—while Dedrone crossed $100 million in revenue, validating the acquisition thesis. Management raised full-year revenue growth guidance to 32%-34% from 30%-32%, with Adjusted EBITDA margin held at 25.5%. Future contracted bookings grew 41% to $15.1 billion, including the largest TASER order ever and two nine-figure city deals. International and enterprise bookings each roughly tripled, showing diversification beyond core U.S. public safety. This follows the CEO's June commentary on Dedrone's momentum and recent insider sales under a 10b5-1 plan. The raised outlook and record pipeline suggest sustained momentum heading into the second half.
At the time of this announcement, AXON was trading at $566.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $49.1B. The 52-week trading range was $339.01 to $885.92. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: PR Newswire.